Department of Nursing, Zhangjiagang TCM Hospital, Nanjing University of Chinese Medicine, 215600, Zhangjiagang, China.
Department of Respiratory, Zhangjiagang TCM Hospital, Nanjing University of Chinese Medicine, 215600, Zhangjiagang, China.
BMC Gastroenterol. 2022 Nov 23;22(1):483. doi: 10.1186/s12876-022-02506-4.
Non-alcoholic simple fatty liver disease patients have very low compliance with almost all types of physical activities. A transtheoretical model-oriented lifestyle modification plan awakens the patient's consciousness in the pre-intention stage. Aim to evaluate whether a management by stages of change plan based on the Transtheoretical Model and Stages of Change promoted behavior change for patients with non-alcoholic simple fatty liver disease.
Patients with simple fatty liver diagnosed from July to December 2019 were randomly divided into the transtheoretical model and non-transtheoretical model groups. Primary outcome was change in health belief and health behavior based on questionnaires. Secondary outcomes included changes in blood lipids, body mass indexes, and waist circumference 12-months after intervention.
Of 200 enrolled patients 194 were analyzed (non-transtheoretical model group n = 98, transtheoretical model group n = 96). After intervention, total health belief scores (120.91 ± 4.94 vs. 118.82 ± 5.48) and total health behavior scores (131.71 ± 5.87 vs. 119.96 ± 7.12) were higher in the transtheoretical model group (all P < 0.05). Blood lipids, body mass index, and waist circumference more obviously improved in the transtheoretical model group (all P < 0.05).
A transtheoretical model-based lifestyle modification intervention can be effectively applied to patients with non-alcoholic simple fatty liver.
ChiCTR2100049354. The registration date is August 1, 2021.
非酒精性单纯性脂肪肝患者对几乎所有类型的体育活动的依从性都非常低。基于跨理论模型的生活方式改变计划可以在预意向阶段唤醒患者的意识。本研究旨在评估基于跨理论模型和改变阶段的管理计划是否可以促进非酒精性单纯性脂肪肝患者的行为改变。
2019 年 7 月至 12 月期间诊断为单纯性脂肪肝的患者被随机分为跨理论模型组和非跨理论模型组。主要结局是基于问卷评估健康信念和健康行为的变化。次要结局包括干预 12 个月后血脂、体重指数和腰围的变化。
共纳入 200 例患者,其中 194 例进行了分析(非跨理论模型组 n=98,跨理论模型组 n=96)。干预后,跨理论模型组的总健康信念评分(120.91±4.94 比 118.82±5.48)和总健康行为评分(131.71±5.87 比 119.96±7.12)均较高(均 P<0.05)。跨理论模型组的血脂、体重指数和腰围改善更为明显(均 P<0.05)。
基于跨理论模型的生活方式改变干预可有效应用于非酒精性单纯性脂肪肝患者。
ChiCTR2100049354,登记日期:2021 年 8 月 1 日。